Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, Conference Calls/ Webcasts

Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call


BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Conference Call Details

Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BIc379f170a12b404ca1a244e8b51e9a3e. The call can also be accessed via a live audio webcast that will be available online at https://investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Option Care Health

Option Care Health is the nation's largest independent provider of home and alternate site infusion services. With over 7,500 team members including more than 4,500 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at OptionCareHealth.com.

For Investor Inquiries:

Mike Shapiro, Chief Financial Officer
Option Care Health
312.940.2538
[email protected]



These press releases may also interest you

at 10:15
"As I entered my twenty-year long tenure as a labor and delivery registered nurse, I often pondered if there was a way of accounting and documenting my presence at a patient's bedside, primarily during an emergency," said an inventor, from Rio...

at 10:15
Biologics Safety Testing Market in terms of revenue was estimated to be worth $4.2 billion in 2024 and is poised to reach $7.2 billion by 2029, growing at a CAGR of 11.1% from 2024 to 2029 according to a new report by MarketsandMarketstm. Some...

at 10:15
Charter Oak State College (http://www.CharterOak.edu/FinishCollege) offers a virtual Undergraduate Open House Wednesday, June 12, 2024, 5:30 PM ET via Zoom for prospective...

at 10:15
Eye disease and trauma are common among many animals including dogs, cats, horses, rabbits and snakes but all too often, veterinarians need to refer those patients to a specialist because they lack the skills or confidence to treat the animals...

at 10:15
Employers' Forum of Indiana introduced Sage Transparencytm 2.0, a major update to the free, publicly accessible hospital price and quality dashboard, today at the National Healthcare Price Transparency Conference in Indianapolis. Sage...

at 10:05
PhotoPharmics, the leader in specialized phototherapy for neurodegenerative diseases, today announced the successful enrollment of its first 25 patients into the Celeste Light for PD Trial. This groundbreaking trial represents a significant...



News published on and distributed by: